(Date:12/6/2009)... Boehringer Ingelheim today announced results from the RE-COVER(TM) ... direct thrombin inhibitor (DTI),(2) compared to dose-adjusted warfarin ... the trial were presented at the 51st American ... online in the New England Journal of ... primary outcome of the trial, six month incidence ...
(Date:12/4/2009)... Alberta Centre for Advanced Micro Nano Technology Products ... seminar, , EDMONTON, Dec. 4 /PRNewswire/ - Today ... how technologies like nanotechnology, biomaterials and microfluidics can ... innovative healthcare products that help promote health and ...
(Date:12/3/2009)... Houston, LLC announced today that it has updated ... vertical sleeve gastrectomy , along with the ... sleeve gastrectomy procedure at the facility was performed by ... October 20, 2009. The patient is reported as doing ...
(Date:12/3/2009)... FRANCISCO, Dec. 3 VIA Pharmaceuticals, Inc. (Nasdaq: ... of compounds for the treatment of cardiovascular and metabolic ... patient visit in its Phase 2 FDG-PET clinical trial ... patients and was carried out at five sites in ...
Breaking Biology Technology:RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 2RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 3RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 4RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 5RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 6Alberta companies delivering new products to the health & medical marketplace 2JourneyLite of Houston Now Offering Sleeve Gastrectomy 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 3VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 4... ADVENTRX Pharmaceuticals,Inc. (Amex: ANX ) a biopharmaceutical ... candidates for the treatment,of cancer and infectious diseases, ... officer, is scheduled to present at the 2007,Thomas ... at 1:30 p.m. Eastern Daylight Time. The conference ...
... - ... ... PDL BioPharma, Inc.,(PDL) (Nasdaq: PDLI ) today announced a ... of novel antibodies in,oncology and select immunological diseases, following a months-long,business ...
... Aug. 28 The American Chemical Society,(ACS) presented the ... prestigious 2007 Heroes of Chemistry award this week,at the ... new 100,percent renewable ingredient -- the first of its ... Tenn., by the DuPont Tate & Lyle Bio,Products joint ...
Other Biology Technology:ADVENTRX Pharmaceuticals to Present at the 2007 Thomas Weisel Partners Healthcare Conference 2PDL BioPharma Announces Significant Strategic and Portfolio Changes to Focus on Antibody Discovery and Development 2PDL BioPharma Announces Significant Strategic and Portfolio Changes to Focus on Antibody Discovery and Development 3PDL BioPharma Announces Significant Strategic and Portfolio Changes to Focus on Antibody Discovery and Development 4PDL BioPharma Announces Significant Strategic and Portfolio Changes to Focus on Antibody Discovery and Development 5DuPont, Genencor International and Tate & Lyle Honored for Groundbreaking Work in Developing Bio-PDO(TM) 2DuPont, Genencor International and Tate & Lyle Honored for Groundbreaking Work in Developing Bio-PDO(TM) 3DuPont, Genencor International and Tate & Lyle Honored for Groundbreaking Work in Developing Bio-PDO(TM) 4(Date:12/3/2009)... A coating on windows or solar panels that repels ... next electric car? New Tel Aviv University research, just ... in assembling peptides at the nano-scale level that could ... few years. , Operating in the range of 100 ...
(Date:12/3/2009)... in warmer water, according to an intriguing new study suggesting ... Experiments with two species of young damselfish on Australia,s Great ... reef fish are either consistently timid, or consistently bold, and ... temperatures rise. , A slight lift of just one or ...
(Date:12/3/2009)... scientists from the U.S. Department of Energy,s (DOE) Brookhaven ... Science has made a major step in understanding how ... necessary to carry out important biological processes. The research, ... Nature Structural & Molecular Biology , confirms that many ...
Breaking Biology News(10 mins):A window that washes itself? 2Fish with attitude: Some like it hot 2Grooving down the helix 2Grooving down the helix 3Managed Health Services Partners With Milwaukee Health Services to Increase Access to Care for Underserved Communities 48218 1Managed Health Services Partners With Milwaukee Health Services to Increase Access to Care for Underserved Communities 48218 2Managed Health Services Partners With Milwaukee Health Services to Increase Access to Care for Underserved Communities 48218 3PHOENIX AHF Magic Johnson HIV Testing Caravan 26 Southwest Center for HIV AIDS to Host Free HIV Testing Event at Off Chute Too 48214 1PHOENIX AHF Magic Johnson HIV Testing Caravan 26 Southwest Center for HIV AIDS to Host Free HIV Testing Event at Off Chute Too 48214 2PHOENIX AHF Magic Johnson HIV Testing Caravan 26 Southwest Center for HIV AIDS to Host Free HIV Testing Event at Off Chute Too 48214 3PHOENIX AHF Magic Johnson HIV Testing Caravan 26 Southwest Center for HIV AIDS to Host Free HIV Testing Event at Off Chute Too 48214 4PHOENIX AHF Magic Johnson HIV Testing Caravan 26 Southwest Center for HIV AIDS to Host Free HIV Testing Event at Off Chute Too 48214 5PHOENIX AHF Magic Johnson HIV Testing Caravan 26 Southwest Center for HIV AIDS to Host Free HIV Testing Event at Off Chute Too 48214 6Caliper Life Sciences to Webcast Investor Session of Open House 12528 1Caliper Life Sciences to Webcast Investor Session of Open House 12528 2... 2 Detection System combines the indirect ... principle and Signets unique formulation of ... and reliablility. Signet reagents will achieve ... and automated protocols. ,Signets USA ...
Each bottle contains: Bromophenol Blue 0.25% w/v , Xylene Cyanol FF 0.25%, Glycerol solution 30% w/v...
XEDAR Antibody...
Rabbit Anti-JNK1/SAPK pan, Polyclonal Antibody...
Biology Products: